Average Co-Inventor Count = 4.32
ph-index = 12
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Novo Nordisk A/s (20 from 1,777 patents)
2. Novo Nordisk Healthcare Ag (3 from 88 patents)
3. Other (2 from 832,843 patents)
25 patents:
1. 11135275 - Coagulation factor-targeting to TREM-like transcript 1 (TLT-1) on activated platelets
2. 8865868 - Conjugated proteins with prolonged in vivo efficacy
3. 8450459 - IL-21 derivatives and variants
4. 7897560 - Plasma protein affinity tags
5. 7576062 - Compounds with growth hormone releasing properties
6. 7524813 - Selectively conjugated peptides and methods of making the same
7. 7186721 - Substituted hexahydropyrrolo[1,2-a]pyrazines, octahydropyrido[1,2-a]-pyrazines and decahydropyrazino[1,2-a]azepines
8. 7101898 - Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes
9. 6939880 - Compounds with growth hormone releasing properties
10. 6919315 - Compounds with growth hormone releasing properties
11. 6908926 - Substituted imidazoles, their preparation and use
12. 6906060 - Substituted hexahydropyrrolo[1,2-a]pyrazines, octahydropyrido[1,2-a]-pyrazines and decahydropyrazino[1,2-a]azepines
13. 6756384 - Imidazole compounds
14. 6555570 - Compounds with growth hormone releasing properties
15. 6437147 - Imidazole compounds